Oxygen therapy for interstitial lung disease: A systematic review

European Respiratory Review

Volumn 26, Issue 143, 2017, Pages

  Bell, Emily C ^a   Cox, Narelle S ^a,b,c   Goh, Nicole ^c,d,e   Glaspole, Ian ^a,e   Westall, Glen P ^a,e   Watson, Alice ^b   Holland, Anne E ^b,c,f  

^a MONASH UNIVERSITY   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c Institute for Breathing and Sleep   (Australia)

^d AUSTIN HEALTH   (Australia)

^e General and Transplant Surgeon   (Australia)

^f NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DYSPNEA; EXERCISE; HUMAN; INTERSTITIAL LUNG DISEASE; LONG TERM CARE; META ANALYSIS; MODIFIED BORG DYSPNEA SCORE; MORTALITY; OXYGEN THERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE ASSESSMENT; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; THERAPY EFFECT; VISUAL ANALOG SCALE; AGED; CHI SQUARE DISTRIBUTION; CONVALESCENCE; EXERCISE TOLERANCE; FEMALE; LUNG; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; TIME FACTOR; TREATMENT OUTCOME;

AGED; CHI-SQUARE DISTRIBUTION; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; OXYGEN INHALATION THERAPY; QUALITY OF LIFE; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 85013743198     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.0080-2016     Document Type: Review

References (27)

1. Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 2015; 192: e3–e19.
2. Crockett AJ, Cranston JM, Antic N. Domiciliary oxygen for interstitial lung disease. Cochrane Database Syst Rev 2001; 3: CD002883.
3. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980; 93: 391–398.
4. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981; 1: 681–686.
5. Sharp C, Adamali H, Millar AB. Ambulatory and short-burst oxygen for interstitial lung disease. Cochrane Database Syst Rev 2016; 7: CD011716.
6. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Handbook. cochrane.org Date last accessed: January 1, 2016. Date last updated March 2011.
7. Hirji KF, Fagerland MW. Calculating unreported confidence intervals for paired data. BMC Med Res Methodol 2011; 11: 66.
8. Anderson SD, Bye PT. Exercise testing in the evaluation of diffuse interstitial lung disease. Aust N Z J Med 1984; 14: 762–768.
9. Bye PT, Anderson SD, Woolcock AJ, et al. Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen. Am Rev Respir Dis 1982; 126: 1005–1012.
10. Swinburn CR, Mould H, Stone TN, et al. Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. Am Rev Respir Dis 1991; 143: 913–915.
11. Harris-Eze AO, Sridhar G, Clemens RE, et al. Oxygen improves maximal exercise performance in interstitial lung disease. Am J Respir Crit Care Med 1994; 150: 1616–1622.
12. Pouwels-Fry S, Pouwels S, Fournier C, et al. Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25: 133–139.
13. Visca D, Montgomery A, de Lauretis A, et al. Ambulatory oxygen in interstitial lung disease. Eur Respir J 2011; 38: 987–990.
14. Frank RC, Hicks S, Duck AM, et al. Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit? Eur Respir J 2012; 40: 269–270.
15. Nishiyama O, Miyajima H, Fukai Y, et al. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia. Respir Med 2013; 107: 1241–1246.
16. Crockett AJ, Alpers JH, Moss JR. Home oxygen therapy: an audit of survival. Aust N Z J Med 1991; 21: 217–221.
17. Chailleux E, Fauroux B, Binet F, et al. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. Chest 1996; 109: 741–749.
18. Douglas WW, Ryu JH, Schroeder DR. Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival. Am J Respir Crit Care Med 2000; 161: 1172–1178.
19. Tomioka H, Imanaka K, Hashimoto K, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis–cross-sectional and longitudinal study. Intern Med 2007; 46: 1533–1542.
20. Cao M, Wamboldt FS, Brown KK, et al. Supplemental oxygen users with pulmonary fibrosis perceive greater dyspnea than oxygen non-users. Multidiscip Respir Med 2015; 10: 37.
21. Swigris JJ, Gould MK, Wilson SR. Health-related quality of life among patients with idiopathic pulmonary fibrosis. Chest 2005; 127: 284–294.
22. Duck A, Spencer LG, Bailey S, et al. Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis. J Adv Nurs 2015; 71: 1055–1065.
23. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185: 435–452.
24. Johnson MJ, Bland JM, Oxberry SG, et al. Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage 2013; 46: 957–963.
25. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014; 44: 1428–1446.
26. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788–824.
27. Belkin A, Albright K, Swigris JJ. A qualitative study of informal caregivers’ perspectives on the effects of idiopathic pulmonary fibrosis. BMJ Open Respir Res 2014; 1: e000007.